Biogen buys a brain disorder drug for $217 million, but needs to go bigger, analyst says

Biogen reported fourth-quarter revenue of $3.31 billion, above the $3.1 billion expected from analysts polled by Thomson Reuters.
Source: CNBC

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>